These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25456869)

  • 1. Heterogeneity in statin indications within the 2013 american college of cardiology/american heart association guidelines.
    Shah RV; Rubenfire M; Brook RD; Lima JA; Nallamothu B; Murthy VL
    Am J Cardiol; 2015 Jan; 115(1):27-33. PubMed ID: 25456869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Verma AA; Jimenez MP; Subramanian SV; Sniderman AD; Razak F
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28912201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of new cholesterol guidelines to a population-based sample.
    Pencina MJ; Navar-Boggan AM; D'Agostino RB; Williams K; Neely B; Sniderman AD; Peterson ED
    N Engl J Med; 2014 Apr; 370(15):1422-31. PubMed ID: 24645848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
    Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
    J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile.
    Echeverría G; Dussaillant C; Villarroel L; Rigotti A
    J Clin Lipidol; 2016; 10(1):192-8.e1. PubMed ID: 26892136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging.
    Johnson KM; Dowe DA
    J Am Coll Cardiol; 2014 Sep; 64(9):910-9. PubMed ID: 25169177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender.
    Goyal A; Cooper HA; Aronow WS; Nagpal P; Yandrapalli S; Nabors CC; Frishman WH
    Am J Med; 2018 Oct; 131(10):1234-1237. PubMed ID: 29928863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
    Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
    Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Pediatric and Adult Guidelines for Treatment of Lipid Levels Among US Adolescents Transitioning to Young Adulthood.
    Gooding HC; Rodday AM; Wong JB; Gillman MW; Lloyd-Jones DM; Leslie LK; de Ferranti SD
    JAMA Pediatr; 2015 Jun; 169(6):569-74. PubMed ID: 25845026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.
    Tournadre A; Tatar Z; Pereira B; Chevreau M; Gossec L; Gaudin P; Soubrier M; Dougados M
    Int J Cardiol; 2015 Mar; 183():149-54. PubMed ID: 25666124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of the American College of Cardiology/American Heart Association guidelines for the treatment of blood cholesterol for a rural community: Data from the Heart of New Ulm Project.
    Miedema MD; Sidebottom AC; Sillah A; Benson G; Knickelbine T; VanWormer JJ
    J Clin Lipidol; 2017; 11(1):94-101. PubMed ID: 28391916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
    Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
    BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events.
    Ko MJ; Kim YJ; Park CM; Lee SM; Lee WJ; Pencina MJ; Navar-Boggan AM; Park DW
    Am Heart J; 2015 Sep; 170(3):598-605.e7. PubMed ID: 26385045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.
    Karmali KN; Goff DC; Ning H; Lloyd-Jones DM
    J Am Coll Cardiol; 2014 Sep; 64(10):959-68. PubMed ID: 25190228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities for improving cardiovascular health outcomes in adults younger than 65 years with guideline-recommended statin therapy.
    Sarasua SM; Li J; Hernandez GT; Ferdinand KC; Tobin JN; Fiscella KA; Jones DW; Sinopoli A; Egan BM
    J Clin Hypertens (Greenwich); 2017 Sep; 19(9):850-860. PubMed ID: 28480530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.
    Thanassoulis G; Williams K; Altobelli KK; Pencina MJ; Cannon CP; Sniderman AD
    Circulation; 2016 Apr; 133(16):1574-81. PubMed ID: 26945047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system.
    Sidebottom AC; Vacquier MC; Jensen JC; Bradley SM; Knickelbine T; Strauss C; Miedema MD
    Clin Cardiol; 2020 Jun; 43(6):560-567. PubMed ID: 32104922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey.
    Spatz ES; Canavan ME; Desai MM
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):41-8. PubMed ID: 20031811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.